Entera Bio Ltd.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ENTX

organization

SIC: 2836

Also known as: ENTERA BIO LTD.

SEC Insider

$656K

130 transactions

Summary

Entera Bio Ltd. (ENTX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $632KSales: —17 insiders

Date	Insider	Type	Value
2026-02-10	Germano Geno J	Buy	$30K
2026-03-09	Germano Geno J	Buy	$26K
2026-02-09	Ellis Sean	Buy	$22K
2026-03-05	Ellis Sean	Buy	$12K
2026-02-09	Rubin Steven D	Buy	$12K
2026-02-10	Taitel Haya	Buy	$11K
2026-02-12	Rubin Steven D	Buy	$7K
2026-05-07	Burshtein Gregory(Chief of R&D)	A	$0
2026-05-07	Yaacov-Garbeli Dana(Chief Financial Officer)	A	$0
2026-05-07	Galitzer Hillel(Chief Operating Officer)	A	$0
2026-01-01	Taitel Haya	A	$0
2026-01-01	Taitel Haya	A	$0
2026-01-01	LIEBERMAN GERALD M	A	$0
2026-01-01	LIEBERMAN GERALD M	A	$0
2026-01-01	Malca Yonatan	A	$0
2026-01-01	Malca Yonatan	A	$0
2026-01-01	Ellis Sean	A	$0
2026-01-01	Ellis Sean	A	$0
2026-01-01	OSTROV GERALD M	A	$0
2026-01-01	OSTROV GERALD M	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Entera Bio Ltd. — Contributions, Lobbying & Contracts | Poliscope